Biohaven Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Developments

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. SPY
3. META
4. ABBV
5. FDX
6. IBM
7. MU
8. PFE
9. AWK
10. ACN

Go back to Biohaven Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Developments

Biohaven Pharma (BHVN) Tops Q4 EPS by 28c

March 1, 2021 7:32 AM EST

Biohaven Pharma (NYSE: BHVN) reported Q4 EPS of ($2.69), $0.28 better than the analyst estimate of ($2.97). Revenue for the quarter came in at $35.1 million versus the consensus estimate of $28.23 million.

For earnings history and earnings-related data on Biohaven Pharma (BHVN) click here.

... More